GlassScriptPhysician profile
Karen N Moon
NPI 1417458357
$12,950.70
in general payments reported to CMS, 2019-2025
32 companies · $3,124 in 2025
The $3,124 reported for 2025 was more than what 94% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,107 · 2020: $31.66 · 2021: $1,290 · 2022: $2,402 · 2023: $3,392 · 2024: $1,605 · 2025: $3,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,554 · Travel and Lodging: $3,549 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,553.50 |
| Travel and Lodging | $3,548.97 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,666.14 | 2019-2025 | Prostep, Augment Injectable, Infinity Adaptis |
| Smith+Nephew, INC. | $3,109.13 | 2022-2025 | Stravix Pl, Oasis, Grafix |
| Reel Surgical, INC. | $1,200.00 | 2021 | |
| Paragon 28, INC. | $1,163.46 | 2019-2024 | Mtp |
| Amgen INC. | $250.29 | 2024-2025 | Krystexxa |
| Arthrex, INC. | $148.15 | 2024 | |
| Linvatec Corporation | $134.23 | 2023 | In2bones USA, Quantum, Colink 2 |
| Horizon Therapeutics Plc | $129.61 | 2021-2023 | Krystexxa |
| Anika Therapeutics, INC. | $128.04 | 2022 | |
| Grt US Holding, INC. | $125.00 | 2022 | |
| Orthofix Medical, INC. | $123.23 | 2022-2023 | Physio-Stim, Spinal-Stim |
| Mimedx Group, INC. | $113.99 | 2025 | |
| Bioventus LLC | $70.00 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $65.52 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Abbott Laboratories | $64.28 | 2024-2025 | Proclaim, Eterna |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $60.22 | 2023-2024 | |
| Organogenesis INC. | $54.80 | 2022-2024 | Puraply |
| Glaxosmithkline, LLC. | $52.55 | 2024 | Bexsero |
| Integra Lifesciences Corporation | $40.68 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paratek Pharmaceuticals, INC. | $28.01 | 2024 | Nuzyra |
| Convatec INC. | $24.36 | 2023 | |
| Advanced Oxygen Therapy INC. | $24.06 | 2024 | Topical Oxygen Chamber For Extremities |
| Lifenet Health | $23.80 | 2024 | Theragenesis Wound Matrix |
| Zimvie INC. | $23.31 | 2022 | |
| Averitas Pharma INC. | $22.93 | 2023 | Qutenza |
| Wright Medical Technology, INC. | $18.80 | 2020 | |
| Cashflow Solutions, LLC | $16.13 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Acera Surgical, INC. | $15.52 | 2023 | Restrata Wound Matrix |
| Axogen | $14.53 | 2019 | |
| Next Science LLC | $13.92 | 2023 | Xperience, Surgx, Blastx |
| Otsuka America Pharmaceutical, INC. | $13.15 | 2019 | |
| Sebela Pharmaceuticals INC. | $12.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.